Breeding Innovation – Strategies for Pharmaceutical CMOs

March 30, 2010 - PRLog -- Interview with: Drew Boyd, Director Marketing Mastery, Ethicon Endo-Surgery Inc. (Johnson & Johnson)




Pharmaceutical products may be the fruit of scientists’ labour, but marketing is often the root of their success. As different parts of some organisations try to take hold of marketing activities, many Chief Marketing Officers (CMOs) are faced with a struggle of having to market their department’s value as innovation facilitators in their own organisation. The only true source of long-term sustainable growth is organic innovation, Drew Boyd, Director Marketing Mastery at Ethicon Endo-Surgery Inc. (Johnson & Johnson) believes, therefore marketing leaders need to re-establish their reputation and credibility. A speaker at the marcus evans PharmaBrand Summit 2010 taking place in Monte-Carlo, 21 - 23 June 2010, Boyd shares his views on innovation as a skill, social media and marketing in emerging markets.

How is your position as Director of Marketing Mastery essential to organisations?

Drew Boyd: My title is a reflection of our need to continue to build our skills and capabilities in terms of marketing techniques, models and frameworks. Marketing executives come from different backgrounds, business schools and work experiences; therefore we felt that having our own internal training programme was a good way of getting everyone to use the same language, terminology and tools. My role is becoming more common now in large organisations, and marketing experience as well as a background in education are both necessary.

To view the complete press release please visit http://www.me-uk.com/summit/newsletter.asp?eventid=16084&...